TerminatedNCT03643159
A Trial to Measure the Difference in All-cause Hospitalizations for Participants Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolarity type I, and Major Depressive Disorder
Medication studyAges 18–63United StatesDepression
Understand this study
Who could participate?
Listed age limits: 18 years to 63 years.
- Listed locations
- Santa Rosa and 4 more locationsSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: June 28, 2018
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 2
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Sponsor type
- Pharmaceutical company
- Study type
- Drug
- Intervention type
- COMBINATION_PRODUCT, Medication / drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 18 Years to 63 Years
- Official registry ID
- NCT03643159
- Official title
Show the full official title
A Multicenter, 180-day Pragmatic Clinical Trial to Measure the Difference in All-cause Hospitalizations for Patients Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and Major Depressive Disorder
Recruitment & locations
TerminatedSanta Rosa · Decatur · Smyrna
2 more locations
- Las Vegas
- Fairlawn
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is Otsuka Pharmaceutical Development & Commercialization, Inc., a pharmaceutical company.
Does this study involve medication?
Yes. The study involves medication, including Aripiprazole or other oral antipsychotics.
Who can participate?
Listed age limits: 18 years to 63 years.
Is this study still recruiting?
The registry lists this study as terminated.
